GlassScriptPhysician profile
Ajit Dwivedi
NPI 1659387447
$699.88
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $84.81 · 2022: $35.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $144.36 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.53 | 2019 | |
| Astellas Pharma US INC | $101.91 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $62.55 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.90 | 2019 | |
| Daiichi Sankyo INC. | $40.80 | 2019-2020 | |
| Boston Scientific Corporation | $35.42 | 2022 | |
| Novo Nordisk INC | $34.35 | 2019-2020 | |
| Sanofi Pasteur INC. | $28.89 | 2019 | |
| Genentech USA, INC. | $23.34 | 2019 | |
| Amarin Pharma, INC. | $20.65 | 2019 | |
| Pfizer INC. | $16.78 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.17 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.32 | 2019 | |
| Lilly USA, LLC | $10.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajit Dwivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.